Literature DB >> 10172075

Cell culture methods for testing biocompatibility.

A Pizzoferrato1, G Ciapetti, S Stea, E Cenni, C R Arciola, D Granchi, L Savarino.   

Abstract

Cell culture systems may be of value in testing the biocompatibility of prosthetic materials before they are introduced into clinical use. In recent years, in vitro methods for assaying biomaterials have gained in importance owing to the growing concern over the use of animals for biomaterials testing. Significant effort is therefore being focused toward developing predictive and quantitative, but also simple and reliable, methods of testing using cultured cells. At present, a number of methods for measuring both the cytotoxicity and the specific cytocompatibility of different materials are available. The usefulness of these systems is no longer confined to screening new materials; they can be used to study the mechanisms of action of various materials during tissue/material interaction. This paper reviews the published literature on the use of cell culture models in evaluating biocompatibility and reports on the personal experience of the authors, who have been using cell culture systems for many years and for different purposes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 10172075     DOI: 10.1016/0267-6605(94)90081-7

Source DB:  PubMed          Journal:  Clin Mater        ISSN: 0267-6605


  15 in total

1.  Double-plating of ovine critical sized defects of the tibia: a low morbidity model enabling continuous in vivo monitoring of bone healing.

Authors:  Joachim A Hahn; Tanja S Witte; Daniel Arens; Alexandra Pearce; Simon Pearce
Journal:  BMC Musculoskelet Disord       Date:  2011-09-29       Impact factor: 2.362

2.  In vitro evaluation of a new injectable calcium phosphate material.

Authors:  G Grimandi; P Weiss; F Millot; G Daculsi
Journal:  J Biomed Mater Res       Date:  1998-03-15

3.  45S5 Bioglass(®)-MWCNT composite: processing and bioactivity.

Authors:  Harshit Porwal; Mehdi Estili; Alina Grünewald; Salvatore Grasso; Rainer Detsch; Chunfeng Hu; Yoshio Sakka; Aldo R Boccaccini; Mike J Reece
Journal:  J Mater Sci Mater Med       Date:  2015-06-25       Impact factor: 3.896

4.  Genotoxicity in gingival cells of patients undergoing tooth restoration with two different dental composite materials.

Authors:  Antonija Tadin; Nada Galic; Marin Mladinic; Danijela Marovic; Ivan Kovacic; Davor Zeljezic
Journal:  Clin Oral Investig       Date:  2013-02-05       Impact factor: 3.573

5.  Maximizing Fibroblast Adhesion on Protein-Coated Surfaces Using Microfluidic Cell Printing.

Authors:  S N Davidoff; D Au; B K Gale; B D Brooks; A E Brooks
Journal:  RSC Adv       Date:  2015-11-18       Impact factor: 3.361

6.  Effect of starch-based biomaterials on the in vitro proliferation and viability of osteoblast-like cells.

Authors:  A P Marques; H R Cruz; O P Coutinho; R L Reis
Journal:  J Mater Sci Mater Med       Date:  2005-09       Impact factor: 3.896

7.  The response of primary rat and human osteoblasts and an immortalized rat osteoblast cell line to orthopaedic materials: comparative sensitivity of several toxicity indices.

Authors:  R Macnair; E H Rodgers; C Macdonald; A Wykman; I Goldie; M H Grant
Journal:  J Mater Sci Mater Med       Date:  1997-02       Impact factor: 3.896

8.  The use of rat, rabbit or human bone marrow derived cells for cytocompatibility evaluation of metallic elements.

Authors:  H Tomás; G S Carvalho; M H Fernandes; A P Freire; L M Abrantes
Journal:  J Mater Sci Mater Med       Date:  1997-04       Impact factor: 3.896

9.  In vitro cytotoxicity of polyphosphoester as a novel injectable alveolar replacement material.

Authors:  Zhixing Zhang; Jing Mao; Xiangli Feng; Jianzhong Xiao; Jinjun Qiu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

10.  In vitro degradation of four magnesium-zinc-strontium alloys and their cytocompatibility with human embryonic stem cells.

Authors:  Aaron F Cipriano; Tong Zhao; Ian Johnson; Ren-Guo Guan; Salvador Garcia; Huinan Liu
Journal:  J Mater Sci Mater Med       Date:  2013-01-30       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.